These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21601503)

  • 1. Not all cystic leukoencephalopathies are "vanishing white matter".
    van der Knaap MS; Scheper GC
    Mol Genet Metab; 2011 Aug; 103(4):413; author reply 414. PubMed ID: 21601503
    [No Abstract]   [Full Text] [Related]  

  • 2. Leukoencephalopathy with vanishing white matter caused by compound heterozygous mutations in mitochondrial complex I NDUFS1 subunit.
    Pagniez-Mammeri H; Landrieu P; Legrand A; Slama A
    Mol Genet Metab; 2010; 101(2-3):297-8. PubMed ID: 20797884
    [No Abstract]   [Full Text] [Related]  

  • 3. Teaching NeuroImages: rapidly progressive leukoencephalopathy in mitochondrial complex I deficiency.
    Baertling F; Schaper J; Mayatepek E; Distelmaier F
    Neurology; 2013 Jul; 81(2):e10-1. PubMed ID: 23836946
    [No Abstract]   [Full Text] [Related]  

  • 4. A homozygous mutation in the NDUFS1 gene presents with a mild cavitating leukoencephalopathy.
    Kashani A; Thiffault I; Dilenge ME; Saint-Martin C; Guerrero K; Tran LT; Shoubridge E; van der Knaap MS; Braverman N; Bernard G
    Neurogenetics; 2014 Aug; 15(3):161-4. PubMed ID: 24952175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broad phenotypic variability in patients with complex I deficiency due to mutations in NDUFS1 and NDUFV1.
    Björkman K; Sofou K; Darin N; Holme E; Kollberg G; Asin-Cayuela J; Holmberg Dahle KM; Oldfors A; Moslemi AR; Tulinius M
    Mitochondrion; 2015 Mar; 21():33-40. PubMed ID: 25615419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic Leucoencephalopathy in NDUFV1 Mutation.
    Wadhwa Y; Rohilla S; Kaushik JS
    Indian J Pediatr; 2018 Dec; 85(12):1128-1131. PubMed ID: 29948731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive cavitating leukoencephalopathy associated with respiratory chain complex I deficiency and a novel mutation in NDUFS1.
    Ferreira M; Torraco A; Rizza T; Fattori F; Meschini MC; Castana C; Go NE; Nargang FE; Duarte M; Piemonte F; Dionisi-Vici C; Videira A; Vilarinho L; Santorelli FM; Carrozzo R; Bertini E
    Neurogenetics; 2011 Feb; 12(1):9-17. PubMed ID: 21203893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Siblings with leukoencephalopathy.
    Breningstall GN; Shoffner J; Patterson RJ
    Semin Pediatr Neurol; 2008 Dec; 15(4):212-5. PubMed ID: 19073330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic Leucoencephalopathy in NDUFV1 Mutation: Correspondence.
    Finsterer J; Zarrouk-Mahjoub S
    Indian J Pediatr; 2019 Feb; 86(2):206-207. PubMed ID: 30155785
    [No Abstract]   [Full Text] [Related]  

  • 10. Teaching NeuroImages: MRI findings in an infant with cavitating leukoencephalopathy.
    Hong A; Assaad P; Karkare S
    Neurology; 2019 Feb; 92(8):e884-e885. PubMed ID: 30777920
    [No Abstract]   [Full Text] [Related]  

  • 11. Diffusion tensor tractography in vanishing white matter disease.
    Pérez-Sánchez S; López-Domínguez JM; Ardúan J; Izquierdo G
    Neurologia; 2011 Mar; 26(2):122-3. PubMed ID: 21163188
    [No Abstract]   [Full Text] [Related]  

  • 12. A rare mutation in EIF2B4 gene in an epileptic child with vanishing white matter disease: a case report.
    Gungor O; Ozkaya AK; Hirfanoglu T; Dilber C; Aydin K
    Genet Couns; 2015; 26(1):41-6. PubMed ID: 26043506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in functional study of EIF2B mutations in leukoencephalopathy with vanishing white matter].
    Leng XR; Wu Y; Jiang YW
    Sheng Li Ke Xue Jin Zhan; 2010 Apr; 41(2):125-8. PubMed ID: 21416999
    [No Abstract]   [Full Text] [Related]  

  • 14. [Left hemiparesis as a sign of onset of vanishing white matter disease. Identification of a new mutation].
    Alías Hernández I; Ramos Lizana J; Aguirre Rodríguez J; Aguilera López P; Garzón Cabrera MI; Entrala Bernal C
    An Pediatr (Barc); 2013 Jul; 79(1):46-9. PubMed ID: 23434401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukoencephalopathy with vanishing white matter: a review.
    Bugiani M; Boor I; Powers JM; Scheper GC; van der Knaap MS
    J Neuropathol Exp Neurol; 2010 Oct; 69(10):987-96. PubMed ID: 20838246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 66-year-old patient with vanishing white matter disease due to the p.Ala87Val EIF2B3 mutation.
    Ghezzi L; Scarpini E; Rango M; Arighi A; Bassi MT; Tenderini E; De Riz M; Jacini F; Fumagalli GG; Pietroboni AM; Galimberti D; Bresolin N
    Neurology; 2012 Nov; 79(20):2077-8. PubMed ID: 23115207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vanishing white matter disease presenting as opsoclonus myoclonus syndrome in childhood--a case report and review of the literature.
    Klingelhoefer L; Misbahuddin A; Jawad T; Mellers J; Jarosz J; Weeks R; Ray Chaudhuri K
    Pediatr Neurol; 2014 Jul; 51(1):157-64. PubMed ID: 24938145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on several/certain adult-onset genetic leukoencephalopathies: clinical signs and molecular confirmation.
    Di Donato I; Dotti MT; Federico A
    J Alzheimers Dis; 2014; 42 Suppl 3():S27-35. PubMed ID: 24958462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Leukoencephalopathy with vanishing white matter: a clinical case of adult onset].
    Pato Pato A; Lorenzo González JR; Cimas Hernando I; Rodríguez-Constenla I
    Neurologia; 2009 Sep; 24(7):504-5. PubMed ID: 21469262
    [No Abstract]   [Full Text] [Related]  

  • 20. Adult-onset vanishing white matter disease with novel missense mutations in a subunit of translational regulator, EIF2B4.
    Kanbayashi T; Saito F; Matsukawa T; Oba H; Hokkoku K; Hatanaka Y; Tsuji S; Sonoo M
    Clin Genet; 2015 Oct; 88(4):401-3. PubMed ID: 25600065
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.